Palmitoylethanolamide (PEA)

DIETARY_SUPPLEMENT5 trials

Sponsors

Rodrigo Machado-Vieira, MD, PhD, MSc, RDC Clinical Pty Ltd, Benha University, Ain Shams University

Conditions

AnxietyBipolar DepressionHealthyPain After Extracorporeal Shock Wave LithotripsyPalmitoylethanolamideSafetySleep Disorder (Disorder)Stress

Phase 2

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

CompletedNCT06229977

Rodrigo Machado-Vieira, MD, PhD, MScBipolar Depression

Start: 2023-05-17End: 2025-07-17Updated: 2026-08-13

Long-Term PEA Safety Study

Active, not recruitingNCT06717867

RDC Clinical Pty LtdHealthy, Safety

Start: 2025-01-22End: 2027-08-01Target: 200Updated: 2026-09-09

Sleep and Stress Study

RecruitingNCT07315516

RDC Clinical Pty LtdSleep Disorder (Disorder), Stress, Anxiety

Start: 2026-04-07End: 2027-02-01Target: 240Updated: 2026-04-23

Unknown Phase

Palmitoylethanolamide vs Ibuprofen for Pain After ESWL

Not yet recruitingNCT07316660

Benha UniversityPain After Extracorporeal Shock Wave Lithotripsy, Palmitoylethanolamide

Start: 2026-01-01End: 2026-07-01Target: 120Updated: 2026-01-05

Palmitoylethanolamide in Ulcerative Colitis

Not yet recruitingNCT07609810

Ain Shams UniversityUlcerative Colitis (UC)

Start: 2026-08-15End: 2029-02-15Target: 60Updated: 2026-07-14